Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trialPeter B. Gilbert, David C. Montefiori, Adrian B. McDermott et al.|Science|2022Cited by 1.2k
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 AcquisitionLawrence Corey, Myron S. Cohen, M. Juliana McElrath et al.|New England Journal of Medicine|2021Cited by 540
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b studyGlenda Gray, James G. Kublin, Mary Allen et al.|The Lancet Infectious Diseases|2011Cited by 385
Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy AdultsFrances Priddy, Deborah D. Brown, James G. Kublin et al.|Clinical Infectious Diseases|2008Cited by 246
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for DeliverySpyros A. Kalams, Scott Parker, Marnie Elizaga et al.|The Journal of Infectious Diseases|2013Cited by 197